OR2-21 | Outcomes of Transcatheter Aortic Valve Replacement in Aortic Regurgitation
Transcatheter aortic valve replacement (TAVR) is the established treatment for severe symptomatic aortic stenosis (AS). However, there is scarcity of data regarding the outcomes of TAVR in aortic regurgitation (AR).
Authors
- Timir K. Paul (ORCID: https://orcid.org/0000-0001-7766-6714)
- Mobeen Z. Haider (ORCID: https://orcid.org/0000-0002-3445-0275)
- Sallam Alrosan
- Lalitsiri Atti
- Junaid Mir (ORCID: https://orcid.org/0000-0002-4587-5121)
- Ayesha Khalil (ORCID: https://orcid.org/0000-0002-8033-3803)
- Yousra Khalid
- Majd Al-Ahmad
- Anas Al-Ahmad
Institutions
- West Virginia University (US)
- University of Tennessee Health Science Center (US)
- Rashid Latif Medical College (PK)
- Latifa Hospital (AE)
- Sparrow Hospital (US)
- University of Missouri Health System (US)
- UCLA Medical Center (US)
- Mayo Hospital (PK)
- Harbor–UCLA Medical Center (US)
- University of Missouri–Kansas City (US)
- University of Missouri (US)
Publication Details
- Journal
- Journal of the Society for Cardiovascular Angiography & Interventions
- Published
- 2025-05-01
- DOI
- https://doi.org/10.1016/j.jscai.2025.102691
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00